COMMUNIQUÉS West-GlobeNewswire

Roche to present new and updated data at ESMO 2019 reinforcing the use of Alecensa in the first-line setting for advanced ALK-positive non-small cell lung cancer

28/09/2019 - 07:00

New real-world data from the Flatiron database supports clinical benefits of Alecensa® (alectinib) across time to treatment discontinuation, real-world progression free survival and overall survival Final PFS and [...]

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

27/09/2019 - 23:30

CRESTWOOD, Ky., and WALTHAM Mass., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]

Iterum Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference

27/09/2019 - 22:30

DUBLIN, Ireland and CHICAGO, Sept. 27, 2019 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat [...]

Iovance Biotherapeutics to Present at Upcoming Conferences

27/09/2019 - 22:30

SAN CARLOS, Calif., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL [...]

Intercept Submits New Drug Application to the U.S. FDA for Obeticholic Acid in Patients with Fibrosis Due to NASH

27/09/2019 - 22:05

NDA supported by positive interim analysis results from REGENERATE Phase 3 study demonstrating OCA’s improvement of liver fibrosis without worsening of NASH NEW YORK, Sept. 27, 2019 (GLOBE NEWSWIRE) -- Intercept [...]

Adamas to Present at Upcoming Cantor Fitzgerald Investor Conference

27/09/2019 - 22:05

EMERYVILLE, Calif., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system disorders, [...]

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

27/09/2019 - 22:05

CHICAGO, Sept. 27, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable [...]

Shineco, Inc. Reports Fiscal Year 2019 Financial Results

27/09/2019 - 22:05

BEIJING, Sept. 27, 2019 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and other [...]

Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

27/09/2019 - 22:05

RADNOR, Pa., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]

Zosano Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

27/09/2019 - 22:05

FREMONT, Calif., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the Board of Directors granted a stock option to purchase 100 [...]

Supertooth Dental Group Acquires the Latest Technology to Allow them to Offer Same-Day Dental Crowns

27/09/2019 - 21:52

BETHESDA, Md., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Supertooth Dental Group has just added the Glidwell dental restoration milling machine to their already high-tech offices. With this new piece of equipment, the dentists [...]

Misonix, Inc. Completes Acquisition of Regenerative Medical Company Solsys Medical

27/09/2019 - 20:50

FARMINGDALE, N.Y., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]

Kezar Life Sciences to Present at the 2019 Cantor Global Healthcare Conference

27/09/2019 - 20:22

SOUTH SAN FRANCISCO, Calif., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet [...]

Lefamulin Evaluation Against Pneumonia 2 (LEAP 2) Study Results Published in the Journal of the American Medical Association

27/09/2019 - 18:15

Nabriva publication of Phase 3 clinical trial results highlights efficacy of XENLETA™ (lefamulin tablets) as novel, short-course, empiric monotherapy for adults with community-acquired bacterial pneumonia (CABP) DUBLIN [...]

Blueberries Medical Receives Approval for Commercial Production & Registration of Five Proprietary CBD Cultivars from the Colombian Institute of Agriculture

27/09/2019 - 17:49

TORONTO, Sept. 27, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a Latin American licensed producer of medicinal cannabis and cannabis- [...]

Aravive Presents Positive Data from Initial 12 Patients in Phase 1b Portion of its Phase 1b/2 Ovarian Cancer Study of AVB-500 in Late Breaking Oral Presentation at European Society for Medical Oncology Congress in Barcelona

27/09/2019 - 16:15

Company additionally reports data on initial 28 evaluable patients in ongoing expansion study as well as expansion cohort dose increase based on drug exposure-response analysis HOUSTON, Sept. 27, 2019 (GLOBE NEWSWIRE [...]

Roche's Tecentriq improves overall survival as a first-line monotherapy in certain people with advanced non-small cell lung cancer

27/09/2019 - 16:00

Phase III IMpower110 study showed Tecentriq monotherapy helped people with advanced non-small cell lung cancer (NSCLC) with high PD-L1 expression live longer compared with chemotherapy alone Data will be shared with [...]

Progyny, Inc. Files Registration Statement for Proposed Initial Public Offering

27/09/2019 - 15:48

NEW YORK, Sept. 27, 2019 (GLOBE NEWSWIRE) -- Progyny, Inc., a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that it has filed [...]

Resverlogix Announces US$12 Million Debenture Financing and Full Repayment of Loan

27/09/2019 - 15:27

CALGARY, Alberta, Sept. 27, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX: RVX) today announces that it has issued a 10% secured convertible debenture in the principal amount of US$12 [...]